OPEN END TURBO OPTIONSSCHEIN SHORT - ASTRAZENECA | Real-time BOERSE MUENCHEN 19:26:54 28/05/2024 BST | ||
| 10.68 EUR | +3.83% |
|
| Current month | -2.78% | ||
| 1 month | -2.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 10.68 | +3.83% |
| 27/05/24 | 10.29 | +0.07% |
| 24/05/24 | 10.28 | +0.28% |
| 23/05/24 | 10.25 | +0.10% |
| 22/05/24 | 10.24 | +0.69% |
Real-time BOERSE MUENCHEN
Last update May 28, 2024 at 07:26 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ASTRAZENECA PLC |
| Issuer | Goldman Sachs |
| WKN | GK9HQY |
| ISIN | DE000GK9HQY1 |
| Date issued | 23/08/2022 |
| Strike | 21,075 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 11.28 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.58 € |
|---|---|
| Lowest since issue | 9.582 € |
| Spread | 0.05 € |
| Spread % | 0.47% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
156.7
USD
Average target price
170.1
USD
Spread / Average Target
+8.55%
- Stock Market
- Certificates
- Certificat
